Psychopharmacology Exam #2 - Drug-Induced Movement Disorder

Descrição

Quiz sobre Psychopharmacology Exam #2 - Drug-Induced Movement Disorder, criado por Melanie Grynsztejn em 23-03-2018.
Melanie Grynsztejn
Quiz por Melanie Grynsztejn, atualizado more than 1 year ago
Melanie Grynsztejn
Criado por Melanie Grynsztejn mais de 6 anos atrás
56
1

Resumo de Recurso

Questão 1

Questão
The following are early onset EPS symptoms
Responda
  • Dystonia
  • Akathisia
  • Parkinsonism
  • Tardive dyskensia

Questão 2

Questão
Which EPS symtom can appear within days
Responda
  • Dystonia
  • Akatsia
  • Parkinsonism
  • Tardive dyskinesia

Questão 3

Questão
Which EPS symptom can appear within weeks?
Responda
  • Dystonia
  • Akathisia
  • Parkinsonsism
  • Tardive dyskenia

Questão 4

Questão
Which EPS symptom can appear within months?
Responda
  • Dystonia
  • Akathisia
  • Parkinsonism
  • Tardive dyskinesia

Questão 5

Questão
Which EPS symtoms can take years to appear?
Responda
  • Dystonia
  • Akathisia
  • Parkinsonism
  • Tardive dyskensia

Questão 6

Questão
Types of drug-induced movement disorders: [blank_start]Acute:[blank_end] Occur within a short duration of treatment onset or dose increase [blank_start]Chronic:[blank_end] Symptoms persist throughout treatment [blank_start]Tardive[blank_end]: Delayed onset of symptoms [blank_start]Withdrawal:[blank_end] Occur in the absence of treatment. May resolve
Responda
  • Acute:
  • Withdrawal:
  • Chronic:
  • Tardive
  • Tardive
  • Withdrawal
  • Withdrawal:
  • Tardive

Questão 7

Questão
Dopamine system pathways include: Mesolimbic: arousal, memory, behavior Mesocortical: cognition, socializaiont Tuberoinfundibular: regulation of prolactin Nigrostriatal: modulation of EPS
Responda
  • True
  • False

Questão 8

Questão
The mechanism for dystonia is
Responda
  • Dopamine deficiency in the basal ganglia and striatum
  • Overactive cholinergic system
  • Dopaminergic/serotonergic or dopaminergic/cholinergic imbalance in the nucleus accumbens
  • Blockade of the striatal dopamine receptors

Questão 9

Questão
What are risk factors for dystonia
Responda
  • Young age
  • H/O ECT
  • Male gender
  • High potency neuroleptics - Haldol, Prolixin
  • Comorbid medical conditions

Questão 10

Questão
Types of dystonia
Responda
  • Opisthotonos
  • Blepharospasm
  • Torticollis
  • Oculogyric crisis
  • Oro-mandibular

Questão 11

Questão
The MOA for akathisia, from the Greek meaning "inability to sit", is:
Responda
  • Dopamine deficiency in the basal ganglia and striatum
  • Dopaminergic/serotonergic or dopaminergic/cholinergic imbalance in the nucleus accumbens, Overstimulation of locus coeruleus.
  • Blockade of the striatal dopamine receptors
  • Striatal dopaminergic hypersensitivity

Questão 12

Questão
Which of the following agents cause akathisia
Responda
  • SSRI
  • Second generation antipsychotics
  • Antiemetics
  • CCB
  • Anti-anxiolytics

Questão 13

Questão
What are some differentials for akathisia
Responda
  • GAD
  • ADHD
  • Agitation
  • MDD

Questão 14

Questão
What are clinical presentation of akathisia
Responda
  • Restlessness
  • Breaking out into song & dance for no reason
  • Fidgety movements/leg swinging
  • Marching in place
  • Rocking from one foot to another
  • Picking

Questão 15

Questão
The risk factors for akathisia include
Responda
  • Advanced age
  • Affective disorder
  • Cognitive impairment
  • Female impersonator performer
  • Female
  • H/O akathisia
  • Iron deficiency
  • High dose/potency/neuroleptics

Questão 16

Questão
Pathophysiology of pseudoparkinsonism is:
Responda
  • Dopamine deficiency in the basal ganglia and striatum
  • Dopaminergic/serotonergic or dopaminergic/cholinergic imbalance in the nucleus accumbens
  • Blockade of the striatal dopamine receptors and depletion of pre-synaptic celft
  • Striatal dopaminergic hypersensitivity and cholinergic deficiency in the basal ganglia

Questão 17

Questão
Parkinsonism = [blank_start]bradykesia[blank_end] Pseudoparkinsonism = [blank_start]apraxic slowness[blank_end]
Responda
  • bradykesia
  • apraxic slowness
  • bradykinesia
  • apraxic slowness

Questão 18

Questão
Parkinsonism = [blank_start]resting tremor[blank_end] Pseudoparkinsonism = [blank_start]essential tremor, myoclonus[blank_end]
Responda
  • resting tremor
  • essential tremor, myoclonus
  • resting tremor
  • essential tremor, myoclonus

Questão 19

Questão
Parkinsonism = [blank_start]lead pipe rigidity[blank_end] Pseudoparkinsonism = [blank_start]paratonic rigidity[blank_end]
Responda
  • lead pipe rigidity
  • paratonic rigidity
  • lead pipe rigidity
  • paratonic rigidity

Questão 20

Questão
Parkinsonism = [blank_start]postural instability[blank_end] Pseudoparkinsonism = [blank_start]frontal ataxia[blank_end]
Responda
  • postural instability
  • frontal ataxia
  • postural instability
  • frontal ataxia

Questão 21

Questão
Parkinsonism = [blank_start]Slow, shuffling gait with festination[blank_end] Pseudoparkinsonism = [blank_start]Slow, shuffling apraxic gait[blank_end]
Responda
  • Slow, shuffling gait with festination
  • Slow, shuffling apraxic gait
  • Slow, shuffling gait with festination
  • Slow, shuffling apraxic gait

Questão 22

Questão
What are risk factors for pseudoparkinsonism?
Responda
  • Female
  • Male
  • Advanced age
  • Central DA receptor binding agents, Metclopramide, phenothiazines
  • AIDS
  • Cancer

Questão 23

Questão
Tardive dyskinesia
Responda
  • If identified early can be reversed
  • is not reversible
  • increased risk with increased use
  • increased use does not cause increases risk
  • early onset
  • late onset

Questão 24

Questão
MOA for tardive dyskinesia
Responda
  • Striatal dopaminergic hypersensitivity
  • Cholinergic deficiency within basal ganglia
  • Oxidative stress and cell injur
  • Genetic susceptibility
  • Glutamate-induced excitotoxicity
  • GABA mediated neuronal dysfunction
  • Blockade of the striatal dopamine receptors

Questão 25

Questão
Which medications most commonly cause tardive dyskinesia?
Responda
  • Meoclopramide
  • Alpha adrenergic agonists
  • SGA
  • FGA

Questão 26

Questão
Clinical presention of tardive dyskinesia
Responda
  • Choreiform - characterized by jerky, involuntary movements, chiefly of the face and extremities
  • Athetoid - characterized by slow, involuntary, convoluted, writhing movements of the fingers, hands, toes, and feet and in some cases, arms, legs, neck and tongue
  • Stereotypic - petitive, nonfunctional motor behavior (e.g., hand waving or head banging), that markedly interferes with normal activities or results in bodily injury.

Questão 27

Questão
EPS can be caused by antiemetics, antieliptics, psychotropics, cardiovascular agents and Levodopa
Responda
  • True
  • False

Questão 28

Questão
EPS can be caused by antiemetics, antieliptics, psychotropics, cardiovascular agents and Levodopa
Responda
  • True
  • False

Questão 29

Questão
The following drugs cause all four movement disorders: dystonia, akathisia, Parkinsonism, tardive dyskinesia
Responda
  • Metoclopramide
  • Prochloraperazine
  • Amoxapine
  • Neuroleptics
  • SSRI
  • Levodopa

Questão 30

Questão
How often should the Abnormal Involuntary Movement Scale (AIMS) be administered?
Responda
  • Baseline then every week x4 then every 3 months
  • Baseline then every week x2 then every 12 months
  • Baseline then every week x2 then every 6 months

Questão 31

Questão
What are overall tips for treatment of EPS?
Responda
  • Stop offending agen (if possible)
  • Reduce the dose
  • Switch to a second generation antipsychotic
  • Treat prophylactically
  • A wing and prayer and refer to anyone else

Questão 32

Questão
Dystonia put in order of line of treatment First line = [blank_start]anticholinergic agents[blank_end] Second line = [blank_start]Baclofen[blank_end] Third line = [blank_start]Benzo[blank_end] Fourth line - [blank_start]Botox[blank_end]
Responda
  • anticholinergic agents
  • Baclofen
  • Benzo
  • Botox

Questão 33

Questão
This is a nice visual/review
Responda
  • True
  • False

Questão 34

Questão
Drug of choice for dystonia is
Responda
  • Beta-blockers, anticholinergics, benzodiazepines, 5-HT2A receptor antagonist, mirtazapine
  • Anticholinergics (benztropine, diphenhydramine, trihexyphenidyl)
  • Clonzaepam, ginkgo biloba

Questão 35

Questão
Drugs of choice for akathisia include
Responda
  • Anticholinergics (benztropine, diphenhydramine, trihexyphenidyl)
  • Beta-blockers, benzodiazepines, 5-HT2A receptor antagonist, mirtazapine
  • Clonazepam, ginkgo biloba

Questão 36

Questão
Mirtazapine (Remeron)
Responda
  • Used in low doses to treat akathisa
  • Used in low doses to treat dystonia
  • Alpha-adrenergic receptor antagonist
  • Alpha-adrenergic receptor agonist
  • Antagonizes 5-HT2 and 3 receptors

Questão 37

Questão
Visual for treatment of akathisia
Responda
  • True
  • False

Questão 38

Questão
Which drugs are used to treat pseudoparkinsonism?
Responda
  • Cogentin (benztropine)
  • Symmetrel (amantadine)
  • Benzodiazepines
  • Mirtazapine (Remeron)
  • Diphenhydramine (Benadryl)

Questão 39

Questão
MOA for amantadine (Symmetrel) is
Responda
  • Dopamine agonist
  • Dopamine antagonist
  • 5-HT2 agonist
  • 5-HT2 antagonist

Questão 40

Questão
Side effects for benztropine (Cogentin) include
Responda
  • Dry mouth
  • Hypotension
  • Diarrhea
  • Constipation
  • Cognitive impairment
  • Sialorrhea

Questão 41

Questão
Side effects for amantadine (Symmetrel) include:
Responda
  • Hypotension
  • Hypertension
  • Agitation
  • Sedation
  • Worsening s/s of psychosis

Questão 42

Questão
Which drugs are used in the treatment of tardive dyskinesia
Responda
  • Diltiazem
  • Baclofen
  • Galantamine
  • Clonazepam
  • Ginkgo biloba

Questão 43

Questão
What is the first FDA approved medication for Tardive Dyskinesia
Responda
  • Velbeazine (Ingrezza)
  • Benztropine (Cogentin)
  • Trihexphenidyl (Artane)
  • Amantadine (Symmetrel)

Questão 44

Questão
What is the MOA for valbenazine (Ingrezza)?
Responda
  • Blocks alpha-adrenergic receptors and antagonizes 5-HT2 and 3 receptors
  • Reversible inhibition of vesicular monoamine transporter 2 (VMAT2), a transporter that regulates monoamine uptake from the cytoplasm to the synaptic vesicle for storage and release
  • Increase in synthesis and release of dopamine, and inhibition of dopamine uptake.
  • Selective M1 muscarinic acetylcholine receptor antagonist. It is able to discriminate between the M1 (cortical or neuronal) and the peripheral muscarinic subtypes (cardiac and glandular)

Questão 45

Questão
Acute [blank_start]laryngeal[blank_end] dystonia is considered a medical emergency. Must seek treatment immediately. May require IV diphenhydramine
Responda
  • laryngeal

Questão 46

Questão
Velbenazine is extensively metabolized by hydrolysis to form active metabolite and by oxidative metabolism to form mono-oxidized valbenazine and other minor metabolites
Responda
  • True
  • False

Questão 47

Questão
High fat meals may [blank_start]decrease[blank_end] absorption of valbenazine (Ingrezza)
Responda
  • decrease
  • increase

Questão 48

Questão
Common adverse side effects of valbenazine (Ingrezza) include:
Responda
  • Fatigue
  • HA
  • Constipation
  • Diarrhea
  • UTI
  • Somnolence

Questão 49

Questão
Warnings for valbenazine (Ingrezza) include:
Responda
  • Somnolence
  • QTc prolongation
  • Pregnancy/breastfeeding
  • Hypertension

Questão 50

Questão
Valbenazine should not be used in:
Responda
  • Severe renal impairment (< 30 mL/min)
  • CHF
  • Cirrhosis
  • Pancreatitis

Questão 51

Questão
Strong 3A4/2D6 inhibitors: [blank_start]Increase[blank_end] valbenazine concentration Strong 3A4 inducer: [blank_start]Decrease[blank_end] valbenazine concentration
Responda
  • Increase
  • Decrease
  • Increase
  • Decrease

Questão 52

Questão
Valbenazine (Ingrezza) interacts with MAOIs by [blank_start]increasing[blank_end] the monamine NT in the synapse
Responda
  • increasing
  • decreasing

Questão 53

Questão
Valbenazine (Ingrezza) interacts with digoxin and [blank_start]increase[blank_end]s the digoxin concentration by p-glycoprotein [blank_start]inhibtion[blank_end]
Responda
  • increase
  • decreases
  • inhibtion
  • inducer

Questão 54

Questão
Deutetrabenazine (Austedo) is used for the treatment of chorea and schizophrenia/schizoaffective disorder. It is metabolized by CYP2D6
Responda
  • True
  • False

Semelhante

Didática com Mapa Mental Online
Alessandra S.
Estudo da Vegetação
Alessandra S.
Guia para Estudar Física
Alessandra S.
Simulado para concursos públicos
Alessandra S.
Dos Mitos à Filosofia...
KauanM
HISTÓRIA REVOLUÇÃO FRANCESA
neusamiotto
Citologia
GoConqr suporte .
Improbidade Administrativa - Lei 8429/92 - Art. 10
Suzy Nobre
Mapa Conceitual
Eduardo Morais
Panorama econômico da América Latina
Carolina Foganholo
Planejamento e Controle da Produção
Luciana Amaral Pereira Freire